We’re continuing to try to find out more about the developing story surrounding Carsten Carlberg. Carlberg, as we have reported, was senior author on two papers retracted last year because one of the authors, a graduate student in Carlberg’s lab at the University of Eastern Finland (formerly Kuopio), fabricated data.
Carlberg holds a dual appointment with the University of Luxembourg, which recently announced the results of a months-long investigation into his behavior.
In November, we reported on two retractions in Cell and the Journal of Molecular Biology involving misconduct in the lab of biochemist Carsten Carlberg, of the University of Eastern Finland, in Kuopio.
Carlberg also holds an appointment in computational biology at the University of Luxembourg, which last year launched an investigation — at his behest, he says — into the case. Well, the officials in Luxembourg finally have spoken, and Carlberg, it seems, may soon be out of his job there, the Tageblatt newspaper reports.
Carlberg, to our knowledge, has never been accused of ethical violations in the case, and the inquiry didn’t change that. Rather, the bad actor appears to be his former post-doc graduate student in Finland, Tatjana Degenhardt. But the University of Luxembourg may seek to dismiss Carlberg after concluding that, as the senior author of the two retracted articles, he bore responsibility for the validity of the results and, by implication, the deception.
Retraction Watch readers may have been following the case of Silvia Bulfone-Paus, whose lab has been forced to retract 12 papers amid allegations of scientific misconduct. As is often true in such cases, the story doesn’t end with those retractions. We’ve just become aware of a fascinating exchange in March and April between Bulfone-Paus’s supporters and her home institution, Germany’s Research Center Borstel.
First, some background: Karin Wiebauer, a former post-doc in Bulfone-Paus’s lab, flagged the potential misconduct, in great detail, for Bulfone-Paus in a November 2009 email. (In fact, she had brought it to her attention years earlier.) But Bulfone-Paus did not tell Borstel officials about the allegations until late February 2010. Borstel’s investigation into Bulfone-Paus’s lab began in July 2010.
Once that began, a person referring to himself as “Marco Berns” began emailing officials, journalists, and others about the situation. Nature called that move a “smear campaign,” and the emails “libellous,” but in retrospect they — and Wiebauer’s analysis — appear to have been spot-on, based on the eventual report of the Borstel committee. That report — which found data manipulation by two of Bulfone-Paus’s post-docs — led the institute’s Scientific Advisory Board to ask for Bulfone-Paus’s resignation. She only tendered that a month later, after more pressure.
Back in March, we reported that the journal Computational and Theoretical Chemistry (CTC) had retracted a pair of 2006 papers by a group of Iranian researchers. As the notices stated, the scientists had recalled their articles after detecting “serious errors” with the work post-publication.
At the time, the authors still had three other articles in good standing with CTC. No longer.
A controversial study of how relationships between climate change scientists may affect the field, and that has been dogged by charges of plagiarism, will be retracted, USA Today reports.
We conjecture that certain styles of co-authorship lead to the possibility of group-think, reduced creativity, and the possibility of less rigorous reviewing processes.
Readers may recall a recent post on a study purporting to show that one of the best insurance policies against a retraction is to employ a medical writer. Well, a group of Iranian surgeons did just that. How’d it work out for them?
Of course, since you’re reading about this on Retraction Watch, you already know the answer to that one, don’t you?
The World Journal of Surgery has retracted a 2010 article written by hired guns who apparently decided to perform wordthievery rather than wordsmithery.
If a paper that has never been cited is retracted, will it be missed?
Japanese researchers have retracted an obscure 1996 article in an equally obscure physics journal after concluding — some 15 years later — that their fundamental assertion was mistaken.
The paper, “Uptake and excretion of cobalt in the crustacean Portunus trituberculatus,” in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, purported to show that a form of the element cobalt might be helpful in tracing the growth of Portunus trituberculatus, otherwise known as the blue crab.
That’s the world’s most harvested crab species and a particular favorite in Asia. But don’t confuse it with the Chesapeake Bay blue crab, Callinectes sapidus, of William Warner’s Pulitzer Prize-winning book, Beautiful Swimmers.
The problem with such elemental tracers, it seems, is that crabs moult repeatedly, shedding their shells, along with the elements that build up inside them. According to researchers from the Research Institute for Advanced Science and Technology and the Osaka Prefectural Fisheries Experimental Station, however, a volatile form of cobalt, previously undetected, could be a suitable element for tracing the growth of both crabs and prawns — another important aquaculture species in Asia — over time.
have recently discovered that the cell lines used in their paper were inadvertently misidentified. The cell lines utilized in the paper have now been found to contain the bcr/abl translocation and most likely represent the K562 CML cell line, instead of MMS1 and RPM1 myeloma cell lines. Due to this issue, the relevance of the findings to myeloma and thus, the conclusions of the paper, are not supported by the data. The authors apologize to the readers, reviewers, and editors of Blood for publishing these erroneous data.
That seems straightforward enough, and we couldn’t find any evidence that this problem affected other publications.
The British Journal of Ophthalmology has retracted a 2006 paper which purported to show a link between drugs for erectile dysfunction and a rare form of sudden vision loss called non-arteritic anterior ischaemic optic neuropathy, more commonly known as “Viagra blindness.”
That wouldn’t be terribly interesting, except for this: One of the authors of the paper, a researcher at the University of Alabama named Gerald McGwin Jr., told us that the journal retracted the article because it had become a tool in a lawsuit involving Pfizer, which makes Viagra, and, presumably, men who’d developed blindness after taking the drug:
The article just became too much of a pain in the rear end. It became one of those things where we couldn’t provide all the relevant documentation [to the university, which had to provide records for attorneys]
Ultimately, however, McGwin said that the BJO pulled the plug on the paper.
It was really the journal’s decision to take it out of the literature.
We’re continuing to try to find out more about the developing story surrounding Carsten Carlberg. Carlberg, as we have reported, was senior author on two papers retracted last year because one of the authors, a graduate student in Carlberg’s lab at the University of Eastern Finland (formerly Kuopio), fabricated data.
